menu

Exploring Innovative Targeted Therapies for RET-Rearranged Non-Small Cell Lung Cancer

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Exploring Innovative Targeted Therapies for RET-Rearranged Non-Small Cell Lung Cancer

close
Exploring Innovative Targeted Therapies for RET-Rearranged Non-Small Cell Lung Cancer
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Once we identify RET fusion abnormalities in patients with non-small cell lung cancer, what targeted therapies are available to us? Tune in to hear Dr. Michael Shafique, Assistant Professor of Thoracic Oncology at the Moffitt Cancer Center, share a brief overview of targeted therapies for patients with RET-rearranged non-small cell lung cancer.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Once we identify RET fusion abnormalities in patients with non-small cell lung cancer, what targeted therapies are available to us? Tune in to hear Dr. Michael Shafique, Assistant Professor of Thoracic Oncology at the Moffitt Cancer Center, share a brief overview of targeted therapies for patients with RET-rearranged non-small cell lung cancer.

Facebook Comments

Programs 7/27/21